Well Lead Medical Co Limited v CJ Medical Limited

Decision date: 26 April 2024

Neutral citation: [2024] EWHC 951 (IPEC)

Overall AI summary confidence: high

AI Notice: Any short overview, ratio decidendi summary or obiter dicta summary shown on this page is AI-generated, provided only to help users assess potential relevance more quickly, and may be wholly inaccurate. No liability is accepted for the accuracy of any such summary, regardless of any AI confidence rating shown. Users should check the underlying decision and obtain appropriate legal advice rather than relying on any summary.

Short overview

This short overview is intended to summarise the case, issues and outcome so far as they are supported by the judgment.

AI confidence in this short overview: high

This is an interim injunction hearing where Well Lead Medical sought to restrain CJ Medical from supplying the Seplou Sheath in the UK for alleged infringement of EP(UK) 3 760 143 B1. The court found there was a serious issue to be tried and that Well Lead is the patent proprietor despite registration discrepancies. However the judge concluded damages would be an adequate remedy for the Claimant, so the interim injunction was refused; the trial is listed for January 2025.

Ratio decidendi

This summary is intended to identify the ratio decidendi, meaning the legal reasons for deciding and the binding part of the decision.

AI confidence in this ratio decidendi summary: high

Where a claimant can quantify damages adequately (including by credible sales forecasts and in light of a trial timetable), an interim injunction may properly be refused at the adequacy-of-damages stage (Stage 2) even if there is a serious question to be tried. The court may also treat evidence establishing ownership as sufficient to establish proprietorship despite registration discrepancies on the patent register.

Obiter dicta

This summary is intended to identify obiter dicta, meaning observations made by the way that were not necessary to deciding the case and are not binding.

AI confidence in this obiter dicta summary: medium

The judgment observed that the deterrent effect of an injunction on third-party market entry is fact-sensitive and should not be treated as a general principle, being most relevant at the balance-of-convenience stage. It also suggested that allegations of derogatory market statements by a defendant do not alone justify injunctive relief without evidence of past or likely future conduct and a sufficient nexus to the relief sought.